ARCHIVES

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

This article is from The Cancer Letter archive.

Vol. 12 No. 05 | January 31, 1986

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000

FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24

July 3, 1981

Behavior Scientists To Discuss Cancer Patient Rehabilitation

January 17, 1975

In Brief: Reauthorization Bill Could Go To House Floor Next Week; Packwood Blocks Action In Senate

July 8, 1983

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009